Traditionally, EGFR signals through a complex network of intermediates, including PI3K, Akt, MAPK1, and phospholipase C gamma (PLCG), to facilitate glioma development, which aligns with our observations. This evidence concerns the gene AKT1 and central nervous system cancer.